Atlas companies are custom built to realize their scientific and business potential. The opportunity determines the model—not the other way around. Our portfolio spans a spectrum of investment approaches from asset-centric product plays to big biology drug discovery platforms:
DISCOVER: Identifying true innovation from high-impact science.
DERISK: Proving and maturing the science and technology to guide clinical translation.
SHAPE: Crafting the right business model for each opportunity.
STRENGTHEN: Rolling up our sleeves to position our companies for successful drug development and exits in all market environments.